| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF03345575 |
| P698 | PubMed publication ID | 18362500 |
| P2093 | author name string | N Zhang | |
| J H Li | |||
| J A Wang | |||
| P2860 | cites work | Multilineage potential of adult human mesenchymal stem cells | Q27860737 |
| Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. | Q33208043 | ||
| Diabetic heart dysfunction: is cell transplantation a potential therapy? | Q35184029 | ||
| Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart | Q35581579 | ||
| Diabetic cardiomyopathy: the search for a unifying hypothesis | Q36423632 | ||
| Molecular and cellular mechanisms of myocardial failure | Q41669341 | ||
| Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair | Q42501081 | ||
| Role of angiotensin II in altered expression of molecules responsible for coronary matrix remodeling in insulin-resistant diabetic rats | Q44575150 | ||
| Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta | Q44989718 | ||
| Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishme | Q45883055 | ||
| Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells | Q47820046 | ||
| Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms | Q47945142 | ||
| Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. | Q51371194 | ||
| Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. | Q51710249 | ||
| The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model | Q64377954 | ||
| Efficacy of pancreatic transplantation on cardiovascular alterations in diabetic rats: an ultrastructural and immunohistochemical study | Q74414254 | ||
| Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling | Q83323467 | ||
| P433 | issue | 2 | |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| bone marrow | Q546523 | ||
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 103-110 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Journal of Endocrinological Investigation | Q15766847 |
| P1476 | title | Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy | |
| P478 | volume | 31 |
| Q26998969 | A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods |
| Q33676193 | Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET |
| Q36673690 | Aging-related decrease of human ASC angiogenic potential is reversed by hypoxia preconditioning through ROS production |
| Q47131819 | Anti-inflammatory effects of hypoxia-preconditioned human periodontal ligament cell secretome in an experimental model of multiple sclerosis: a key role of IL-37. |
| Q36357726 | Benefits of hypoxic culture on bone marrow multipotent stromal cells. |
| Q26749552 | Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications |
| Q39017865 | Can the outcomes of mesenchymal stem cell-based therapy for myocardial infarction be improved? Providing weapons and armour to cells |
| Q41773498 | Carbamylated erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in rats with diabetic cardiomyopathy |
| Q21195758 | Cardiac regeneration and diabetes |
| Q28082334 | Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy |
| Q27025754 | Cell based therapies for ischemic stroke: from basic science to bedside |
| Q58791587 | Comparing atmospheric and hypoxic cultured mesenchymal stem cell transcriptome: implication for stem cell therapies targeting intervertebral discs |
| Q30428895 | Diabetes-associated macrovascular complications: cell-based therapy a new tool? |
| Q50437302 | Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy |
| Q35912379 | ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium |
| Q42775721 | Fibrin microbeads loaded with mesenchymal cells support their long-term survival while sealed at room temperature |
| Q35610092 | Ginsenoside Rg1 ameliorates oxidative stress and myocardial apoptosis in streptozotocin-induced diabetic rats. |
| Q26774939 | How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart? |
| Q34103142 | Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis |
| Q36623969 | Hypoxic preconditioning increases the protective effect of bone marrow mesenchymal stem cells on spinal cord ischemia/reperfusion injury |
| Q49962904 | Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation. |
| Q51741106 | Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. |
| Q41212597 | Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy? |
| Q91792198 | Mesenchymal stem cell perspective: cell biology to clinical progress |
| Q33719419 | Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus |
| Q34635689 | Mesenchymal stem cells and inflammatory cardiomyopathy: cardiac homing and beyond |
| Q38272566 | Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis |
| Q38287785 | Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application |
| Q58713633 | Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury |
| Q38005087 | Optimization of the cardiovascular therapeutic properties of mesenchymal stromal/stem cells-taking the next step. |
| Q93366161 | Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury |
| Q38126494 | Preconditioning strategy in stem cell transplantation therapy |
| Q37153287 | Priming adult stem cells by hypoxic pretreatments for applications in regenerative medicine |
| Q33585478 | Promoting vascular repair in the retina: can stem/progenitor cells help? |
| Q38874116 | Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. |
| Q47099846 | Role of SDF-1:CXCR4 in Impaired Post-Myocardial Infarction Cardiac Repair in Diabetes. |
| Q47681355 | Role of hypoxia‑mediated cellular prion protein functional change in stem cells and potential application in angiogenesis (Review). |
| Q26862700 | Stem cell therapy in bladder dysfunction: where are we? And where do we have to go? |
| Q38843402 | Stem cells and diabetic cardiomyopathy: from pathology to therapy |
| Q34773408 | Stem cells in the diabetic infarcted heart |
| Q92308051 | Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome |
| Q42203882 | The caspase-8 shRNA-modified mesenchymal stem cells improve the function of infarcted heart |
| Q26775933 | The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy |
| Q37894482 | The management of myocarditis |
| Q38181982 | The potential of cell-based therapy for diabetes and diabetes-related vascular complications |
| Q36234392 | Therapeutic effect of mesenchymal stem cells on experimentally induced hypertensive cardiomyopathy in adult albino rats |
| Q51823569 | Transplantation of stromal-derived factor 1α and basic fibroblast growth factor primed insulin-producing cells reverses hyperglycaemia in diabetic rats. |
| Q27026688 | Treatment of bladder dysfunction using stem cell or tissue engineering technique |
| Q89619321 | Urodynamic Parameters in Spinal Cord Injury-Induced Neurogenic Bladder Rats after Stem Cell Transplantation: A Narrative Review |
| Q35563408 | Use of human embryonic stem cell derived-mesenchymal cells for cardiac repair |
Search more.